Ling Wang
Impact in
- Pharmacology top 1%
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Bioactive Natural Diterpenoids Research 7
- Pharmacology 45
- Drug-Induced Hepatotoxicity and Protection 13
- Pharmacogenetics and Drug Metabolism 13
- Plant-based Medicinal Research 11
- Pharmacological Effects of Natural Compounds 9
- Co-authors
- Xuehua Jiang (45 shared papers)Zong‐Guang Zhou (6 shared papers)Lie Yang (3 shared papers)Chaojie Wang (1 shared paper)Hongying Chen (1 shared paper)Xiao-Feng Sun (1 shared paper)Bin Zhou (1 shared paper)Jun Gu (1 shared paper)
- Journals
- Biomedical Chromatography (10 papers)Journal of Pharmaceutical and Biomedical Analysis (6 papers)European Journal of Pharmaceutical Sciences (5 papers)Journal of Chromatography B (4 papers)Medical Physics (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Ling Wang
235 papers receiving 3.7k citations
Ling Wang's Hit Papers
Peers
Comparison fields: 5 of 149
- Pharmacology 278
- Cancer Research 393
- Developmental Neuroscience 78
- Oncology 506
- Complementary and alternative medicine 148
Countries citing papers authored by Ling Wang
This map shows the geographic impact of Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wang more than expected).
Fields of papers citing papers by Ling Wang
This network shows the impact of papers produced by Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wang. The network helps show where Ling Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 243 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 164 | |
| 2 | Estimating Global Prevalence of Metabolic Dysfunction-Associated Fatty Liver Disease in Overweight or Obese Adults Hit paper breakdown → | 2021 | 150 |
| 3 | 2013 | 144 | |
| 4 | 2005 | 115 | |
| 5 | 2015 | 95 | |
| 6 | 2013 | 81 | |
| 7 | 2017 | 72 | |
| 8 | 2019 | 70 | |
| 9 | 2019 | 64 | |
| 10 | 2020 | 64 | |
| 11 | 2014 | 56 | |
| 12 | 2009 | 52 | |
| 13 | 2015 | 51 | |
| 14 | 2022 | 49 | |
| 15 | 2007 | 48 | |
| 16 | 2014 | 47 | |
| 17 | 2010 | 47 | |
| 18 | 2006 | 44 | |
| 19 | 2008 | 43 | |
| 20 | 2008 | 42 |
About Ling Wang
Ling Wang is a scholar working on Molecular Biology, Pharmacology, Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 243 papers that have together received 3.7k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (15 papers), Drug-Induced Hepatotoxicity and Protection (13 papers), Pharmacogenetics and Drug Metabolism (13 papers), Plant-based Medicinal Research (11 papers), Pharmacological Effects of Natural Compounds (9 papers), Pregnancy and preeclampsia studies (8 papers), Bioactive Natural Diterpenoids Research (7 papers) and HER2/EGFR in Cancer Research (6 papers). The work is most often cited by research in Pharmacology (278 citations), Cancer Research (393 citations), Developmental Neuroscience (78 citations), Oncology (506 citations) and Complementary and alternative medicine (148 citations). Ling Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xuehua Jiang, Zong‐Guang Zhou, Lie Yang, Chaojie Wang, Hongying Chen, Xiao-Feng Sun, Bin Zhou, Jun Gu, Liang Zheng and Huile Gao. Their work appears in journals such as Biomedical Chromatography, Journal of Pharmaceutical and Biomedical Analysis, European Journal of Pharmaceutical Sciences, Journal of Chromatography B and Medical Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.